Henry McCusker, Regenerative Medicine Investors (11/16/15)
"Mesoblast Ltd. said it expects to raise about $63.8M (CA$95.8M) from the initial public offering, excluding underwriting discounts, commissions and expenses associated with the equity issue. The company will use the proceeds to fund its clinical trial programs, research and development, manufacturing requirements and general administrative expenses. . .the NASDAQ float has brought in enough cash to give Mesoblast '18 months of runway' to fund the final stages of its key clinical trials."
MESO - change of IPO price at last minute, page-105
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |